The Benefits of Pre-Treating Corneas

Article

An approach to pre-treating two corneal conditions that makes for better refractive surgery by Asim Piracha, MD, Louisville, Kentucky, has been published in the Review of Ophthalmology.

An approach to pre-treating two corneal conditions that makes for better refractive surgery by Asim Piracha, MD, Louisville, Kentucky, has been published in the Review of Ophthalmology.

“No one would perform cataract surgery on a post-refractive surgery patient without using every method possible to ensure the most accurate keratometry possible.

“However, if a refractive surgeon performs refractive surgery on a patient with anterior basement membrane dystrophy without treating the ABMD first and then letting the refraction stabilize, his results can be just as unpredictable, since the ABMD can affect the refraction in ways the surgeon can’t foresee. In this article, I’ll explain how I approach ABMD patients, and patients with Salzmann’s nodular degeneration, who desire refractive surgery.”

Read full text.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.